Company intelligence / Profile preview

Stem Genomics

Montpellier, Occitanie, Francestemgenomics.com ↗

Ownership: Private
Development stage: Commercial

Overview

Stem Genomics offers innovative, rapid, and precise quality control solutions to assess the genetic integrity of human stem cells. Its flagship digital PCR-based iCS-digital™ PSC assay enables high-resolution detection of genomic abnormalities in human pluripotent stem cells within days. The company also provides a range of other tests including karyotyping, mycoplasma detection, STR analysis, pluripotency/differentiation assessment, aneuploidy detection via NGS, and custom assays. It serves over 150 clients worldwide across academia and industry.

Modalities: Diagnostic assayDigital PCR-based assayNext Generation Sequencing (NGS)STR analysis (Short Tandem Repeat)
Industry: Molecular Diagnostics

Partnerships

KaryoLogic Inc. (US partner for G-band karyotype services)

Beyond the preview

Go deeper on Stem Genomics.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Stem Genomics.